CLINICAL RESEARCH ORGANIZATION SERVICES AGREEMENT

Illinois, US

Agreement date: [date]

Sponsor: [full legal name and entity type], of [address] (Sponsor).

CRO: [full legal name and entity type], of [address] (CRO).

1. Study and services

Sponsor engages CRO to perform the clinical-research services for the study in Schedule 1 (Study). CRO will perform the stated tasks and deliverables with qualified personnel, reasonable care, the approved protocol, lawful Sponsor instructions, and applicable federal and Illinois requirements.

2. Transfer of regulatory obligations

Schedule 2 must list each Sponsor obligation under 21 CFR part 312 transferred to CRO, or expressly state a complete transfer. CRO accepts only the obligations so identified; all others remain Sponsor's responsibility. CRO will comply with each rule applicable to an accepted obligation and document performance. Changes require a signed amendment to Schedule 2.

3. Sponsor responsibilities

Sponsor retains responsibility for the protocol, investigational product, regulatory submissions, medical and safety decisions, and obligations not transferred in Schedule 2. Sponsor will provide accurate materials, approvals, safety information, and timely decisions, and will not direct a departure from law, the approved protocol, informed consent, or an institutional review board requirement.

4. CRO responsibilities

CRO will use qualified staff and approved subcontractors, document delegation and training, monitor as scheduled, report material deviations and safety information promptly, and permit Sponsor oversight. CRO may not enroll a subject, provide clinical care, act as investigator, hold investigational product, or access identifiable subject information unless Schedule 1 expressly assigns that function and all required approvals, agreements, and safeguards are in place. CRO remains responsible for its subcontractors' services.

5. Data, privacy, and security

Study Data means records generated for the Study, excluding CRO's pre-existing methods and systems. Sponsor owns Study Data upon creation, subject to applicable law and investigator or institution rights. CRO will process personal information only as documented by Sponsor and only for the Study, use reasonable administrative, technical, and physical safeguards, restrict access, and notify Sponsor without undue delay of suspected unauthorized access, use, or disclosure. If CRO will receive protected health information, the parties must execute a compliant business associate agreement before disclosure. This agreement alone authorizes no disclosure contrary to HIPAA, Illinois law, informed consent, or an institutional review board requirement.

6. Records, inspection, and audit

CRO will create accurate, attributable, contemporaneous, original, and complete records and retain them as law, the protocol, and Schedule 1 require. CRO will not destroy Study records without Sponsor's written direction after the retention period. Sponsor may audit relevant records and systems on reasonable notice. CRO will cooperate with lawful inspections and promptly report a material notice or finding concerning the Study.

7. Fees and changes

Sponsor will pay the fixed fees, pass-through costs, invoice milestones, and payment dates in Schedule 3. CRO may incur no pass-through cost above the approved limit without prior written approval, except necessary action to protect a subject from immediate harm. A change to scope, protocol, timing, assumptions, or transferred obligations requires a signed change order stating the effect on fees and schedule.

8. Confidentiality and intellectual property

Each party will use the other's nonpublic scientific, technical, business, and regulatory information only for the Study and disclose it only to persons bound to protect it or as law requires. Sponsor retains Study inventions and results; CRO retains pre-existing tools and methods. CRO assigns its rights in Study-specific deliverables and inventions created within the services and grants Sponsor a perpetual license to embedded CRO material needed to use them.

9. Termination and transition

Either party may terminate for uncured material breach after [number] days' specific written notice. Sponsor may terminate for convenience on [number] days' notice or immediately for subject-safety or regulatory necessity. CRO may suspend affected work if continuing would be unlawful or expose a subject to material risk, after prompt notice when practicable. On termination, CRO will protect subjects, stop unauthorized work, transfer current Study Data and records, account for investigational materials, and provide reasonable transition at Schedule 3 rates. Sponsor will pay earned fees and approved noncancelable costs.

10. General

Each party is responsible for loss caused by its breach, negligence, willful misconduct, or legal violation. No limitation applies to liability that law does not permit the parties to limit. The parties are independent contractors; CRO cannot bind Sponsor. This agreement, signed schedules, and change orders are the entire agreement. Illinois law governs, without displacing controlling federal research law.

SCHEDULE 1 - STUDY AND SERVICES

Protocol, phase, product, sites, services, milestones, deliverables, approved subcontractors, systems, retention period, and Sponsor contacts: [details].

SCHEDULE 2 - TRANSFERRED 21 CFR PART 312 OBLIGATIONS

Specific obligations accepted by CRO, with section references and responsible CRO role: [details].

SCHEDULE 3 - BUDGET

Fees, milestones, pass-through limits, invoice cycle, payment date, and transition rates: [details].

Sponsor: ____________________  Name and title: [name and title]  Date: [date]

CRO: ____________________  Name and title: [name and title]  Date: [date]


---
License: Licensed under CC BY 4.0. Attribution is required when you publish or redistribute this Template or an adapted version to the public. Attribution is not required merely because you use or adapt the Template for your own business or legal purposes, including preparing, negotiating, signing, or exchanging an agreement with a counterparty. License details.
License details: https://contract-templates.getfebruary.ai/license/